246 related articles for article (PubMed ID: 30656741)
1. Targeting the KRAS, p38α, and NF-κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor.
Zarredar H; Pashapour S; Farajnia S; Ansarin K; Baradaran B; Ahmadzadeh V; Safari F
J Cell Biochem; 2019 Jun; 120(6):10670-10677. PubMed ID: 30656741
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells.
Zarredar H; Farajnia S; Ansarin K; Baradaran B; Aria M; Asadi M
Anticancer Agents Med Chem; 2019; 19(5):638-644. PubMed ID: 30827261
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro.
Zarredar H; Pashapour S; Ansarin K; Khalili M; Baghban R; Farajnia S
J Cell Physiol; 2019 Feb; 234(2):1560-1566. PubMed ID: 30132854
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy with KRAS and P38α siRNA Suppresses Colorectal Cancer Growth and Development in SW480 Cell Line.
Kamran S; Seyedrezazadeh E; Shanehbandi D; Asadi M; Zafari V; Shekari N; Namvar L; Zarredar H
J Gastrointest Cancer; 2022 Sep; 53(3):597-604. PubMed ID: 34292499
[TBL] [Abstract][Full Text] [Related]
5. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells.
de Bittencourt Pasquali MA; Gelain DP; Zeidán-Chuliá F; Pires AS; Gasparotto J; Terra SR; Moreira JC
Cell Signal; 2013 Apr; 25(4):939-54. PubMed ID: 23333461
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17A stimulates migration of periodontal ligament fibroblasts via p38 MAPK/NF-κB -dependent MMP-1 expression.
Wu Y; Zhu L; Liu L; Zhang J; Peng B
J Cell Physiol; 2014 Mar; 229(3):292-9. PubMed ID: 23929359
[TBL] [Abstract][Full Text] [Related]
8. Requirement for epithelial p38α in KRAS-driven lung tumor progression.
Vitos-Faleato J; Real SM; Gutierrez-Prat N; Villanueva A; Llonch E; Drosten M; Barbacid M; Nebreda AR
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2588-2596. PubMed ID: 31969449
[TBL] [Abstract][Full Text] [Related]
9. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
11. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
12. (E)-2,4-bis(p-hydroxyphenyl)-2-butenal has an antiproliferative effect on NSCLC cells induced by p38 MAPK-mediated suppression of NF-κB and up-regulation of TNFRSF10B (DR5).
Kollipara PS; Jeong HS; Han SB; Hong JT
Br J Pharmacol; 2013 Mar; 168(6):1471-84. PubMed ID: 23082969
[TBL] [Abstract][Full Text] [Related]
13. Acacetin inhibits the invasion and migration of human non-small cell lung cancer A549 cells by suppressing the p38α MAPK signaling pathway.
Chien ST; Lin SS; Wang CK; Lee YB; Chen KS; Fong Y; Shih YW
Mol Cell Biochem; 2011 Apr; 350(1-2):135-48. PubMed ID: 21210297
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
15. XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.
Kim J; McMillan E; Kim HS; Venkateswaran N; Makkar G; Rodriguez-Canales J; Villalobos P; Neggers JE; Mendiratta S; Wei S; Landesman Y; Senapedis W; Baloglu E; Chow CB; Frink RE; Gao B; Roth M; Minna JD; Daelemans D; Wistuba II; Posner BA; Scaglioni PP; White MA
Nature; 2016 Oct; 538(7623):114-117. PubMed ID: 27680702
[TBL] [Abstract][Full Text] [Related]
16. Targeted nanoconjugate co-delivering siRNA and tyrosine kinase inhibitor to KRAS mutant NSCLC dissociates GAB1-SHP2 post oncogene knockdown.
Srikar R; Suresh D; Zambre A; Taylor K; Chapman S; Leevy M; Upendran A; Kannan R
Sci Rep; 2016 Aug; 6():30245. PubMed ID: 27530552
[TBL] [Abstract][Full Text] [Related]
17. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
18. The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.
Yang H; Xiang S; Kazi A; Sebti SM
J Biol Chem; 2020 Mar; 295(10):3055-3063. PubMed ID: 32001619
[TBL] [Abstract][Full Text] [Related]
19. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription.
Chiacchiera F; Matrone A; Ferrari E; Ingravallo G; Lo Sasso G; Murzilli S; Petruzzelli M; Salvatore L; Moschetta A; Simone C
Cell Death Differ; 2009 Sep; 16(9):1203-14. PubMed ID: 19343039
[TBL] [Abstract][Full Text] [Related]
20. Effects of long non-coding RNA NEAT1 on sepsis-induced brain injury in mice via NF-κB.
Liu WQ; Wang YJ; Zheng Y; Chen X
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3933-3939. PubMed ID: 31115021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
